Cargando…

Association of Vitamin D and secondary hyperparathyroidism with anemia in diabetic kidney disease

INTRODUCTION: Anemia is common in Chronic Kidney Disease (CKD) and diabetes is a major leading risk factor for it. In Diabetic Kidney Disease (DKD), it worsens more, which further increases cardiovascular morbidity and mortality. Despite of adequate iron stores anemia persist, which may be due to im...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sonkar, Satyendra Kumar, Singh, Harendra Pratap, Sonkar, Gyanendra Kumar, Pandey, Sant
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6131998/ https://www.ncbi.nlm.nih.gov/pubmed/30234059 http://dx.doi.org/10.4103/jfmpc.jfmpc_174_17

Ejemplares similares

Cathepsin S as an early biomarker for cardiovascular disease in chronic kidney disease patients
por: Sonkar, Satyendra Kumar, et al.
Publicado: (2022)

An observational study to estimate the level of essential trace elements and its implications in type 2 diabetes mellitus patients
por: Sonkar, Satyendra Kumar, et al.
Publicado: (2021)

Zinc Alpha 2 Glycoprotein as an Early Biomarker of Diabetic Nephropathy in Type 2 Diabetes Mellitus Patients
por: Sonkar, Satyendra K, et al.
Publicado: (2023)

Validity of Indian Diabetes Risk Score and its association with body mass index and glycosylated hemoglobin for screening of diabetes in and around areas of Lucknow
por: Khan, Mohammad Mustufa, et al.
Publicado: (2017)

Association of Pulmonary Hypertension With Inflammatory Markers and Volume Status in Hemodialysis Patients of End-Stage Renal Disease
por: Sonkar, Satyendra K, et al.
Publicado: (2021)

Thyrotoxic Hypokalemic Periodic Paralysis
por: Sonkar, Satyendra Kumar, et al.
Publicado: (2018)

Clinical Profile of Neurological Manifestation in Human Immunodeficiency Virus-positive Patients
por: Sonkar, Satyendra K, et al.
Publicado: (2012)

Vitamin D prohormone in the treatment of secondary hyperparathyroidism in patients with chronic kidney disease
por: Friedl, Claudia, et al.
Publicado: (2017)

Evaluation of Therapies for Secondary Hyperparathyroidism Associated with Vitamin D Insufficiency in Chronic Kidney Disease
por: Strugnell, Stephen A., et al.
Publicado: (2023)

Expression of vitamin D receptor and vitamin D status in patients with oral neoplasms and effect of vitamin D supplementation on quality of life in advanced cancer treatment
por: Anand, Akshay, et al.
Publicado: (2017)

Evaluation of Interactions Between Thyroid Dysfunction in End-Stage Renal Disease Patients: A Cross-Sectional Study
por: Shakya, Shobhit, et al.
Publicado: (2023)

Exacerbation of Hyperparathyroidism, Secondary to a Reduction in Kidney Function, in Individuals With Vitamin D Deficiency
por: Daimon, Makoto, et al.
Publicado: (2020)

Coagulation and fibrinolysis in hyperparathyroidism secondary to vitamin D deficiency
por: Elbers, Laura P B, et al.
Publicado: (2018)

Vitamin D and Secondary Hyperparathyroidism in Chronic Kidney Disease: A Critical Appraisal of the Past, Present, and the Future
por: Brandenburg, Vincent, et al.
Publicado: (2022)

Association of vitamin D deficiency and hyperparathyroidism with anemia: a cross-sectional study
por: Golbahar, Jamal, et al.
Publicado: (2013)

Socio-economic impact of first 21 days nationwide lockdown- 1 on the spread of SARS-COV-2 in India in relation to health
por: Kumar, Satish, et al.
Publicado: (2020)

The Emerging Role of Nutritional Vitamin D in Secondary Hyperparathyroidism in CKD
por: Lu, Chien-Lin, et al.
Publicado: (2018)

Evocalcet with vitamin D receptor activator treatment for secondary hyperparathyroidism
por: Shigematsu, Takashi, et al.
Publicado: (2022)

COVID-19 cases and their outcome among patients with uncommon co-existing illnesses: A lesson from Northern India
por: Reddy, D. Himanshu, et al.
Publicado: (2022)

Detection of undiagnosed and inadequately treated high blood pressure in dentistry by screening
por: Kumar, Satish, et al.
Publicado: (2020)

Nontubercular Bacterial and Fungal Infections in Patients of Chronic Obstructive Pulmonary Disease
por: Khandelwal, Akash, et al.
Publicado: (2023)

Association of vitamin D levels, lipid profile and intima media thickness in HIV positive patients
por: Bajaj, Sarita, et al.
Publicado: (2012)

Treatment of secondary hyperparathyroidism in kidney disease: what we know and do not know about use of calcimimetics and vitamin D analogs
por: Wetmore, James B, et al.
Publicado: (2008)

A learning experience of pandemic COVID-19 management at our medical institute
por: Sonkar, Satyendra Kumar, et al.
Publicado: (2020)

Secondary hyperparathyroidism among Nigerians with chronic kidney disease
por: Gimba, Zumnan M, et al.
Publicado: (2018)

Secondary Hyperparathyroidism in Chronic Kidney Disease: Pathophysiology and Management
por: Habas, Elmukhtar, et al.
Publicado: (2021)

As the World Struggles With the COVID-19 Pandemic, Another Emergency Threat Arrives on the Horizon, the Monkeypox: A Systematic Review
por: Kumar, Satish, et al.
Publicado: (2023)

Effects of Secondary Hyperparathyroidism Treatment on Improvement in Anemia: Results from the MBD-5D Study
por: Tanaka, Motoko, et al.
Publicado: (2016)

Cellulose Acetate 398-10 Asymmetric Membrane Capsules for Osmotically Regulated Delivery of Acyclovir
por: Sonkar, Alka, et al.
Publicado: (2016)

Oral Paricalcitol for the Treatment of Secondary Hyperparathyroidism in Chronic Kidney Disease
por: Cheng, Steven, et al.
Publicado: (2006)

Parathyroid Cell Proliferation in Secondary Hyperparathyroidism of Chronic Kidney Disease
por: Naveh-Many, Tally, et al.
Publicado: (2020)

Vitamin D deficiency, secondary hyperparathyroidism and respiratory insufficiency in hospitalized patients with COVID-19
por: Mazziotti, G., et al.
Publicado: (2021)

Association of MTHFR (C677T) Gene Polymorphism With Breast Cancer in North India
por: Waseem, Mohammad, et al.
Publicado: (2016)

DBS-platform for biomonitoring and toxicokinetics of toxicants: proof of concept using LC-MS/MS analysis of fipronil and its metabolites in blood
por: Raju, Kanumuri Siva Rama, et al.
Publicado: (2016)

Unmasking of primary hyperparathyroidism by Vitamin D therapy
por: Bala, S., et al.
Publicado: (2015)

Vitamin D and Hyperparathyroidism: The Lumleian Lecture 1981
por: Stanbury, S.W.
Publicado: (1981)

Active vitamin D increases the risk of hypercalcaemia in non-dialysis chronic kidney disease patients with secondary hyperparathyroidism: a systematic review and meta-analysis
por: Cozzolino, Mario, et al.
Publicado: (2021)

Association of Secondary Hyperparathyroidism with Hemoglobin Level in Patients with Chronic Kidney Disease
por: Chutia, Happy, et al.
Publicado: (2013)

Recent advances in understanding and managing secondary hyperparathyroidism in chronic kidney disease
por: Rodríguez-Ortiz, María E., et al.
Publicado: (2020)

Secondary and Tertiary Hyperparathyroidism in Chronic Kidney Disease: An Endocrine and Renal Perspective
por: Chandran, Manju, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_s3o1mkh0en3ha6t0gfmnus0keg